KCNB2
Potassium voltage-gated channel subfamily B member 2
Also known as: KCNB2_HUMAN, Kv2.2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92953
- Gene
- KCNB2
- Ensembl
- ENSG00000182674
- Chromosome
- 8
- Canonical length
- 911 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Subcellular location
- Nucleoli,Plasma membrane,Midbody
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shab-related subfamily. This member is a delayed rectifier potassium channel. The gene is expressed in gastrointestinal smooth muscle cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
911 residues, UniProt reviewed canonical sequence.
>Q92953|KCNB2
1 MAEKAPPGLN RKTSRSTLSL PPEPVDIIRS KTCSRRVKIN VGGLNHEVLW RTLDRLPRTR
61 LGKLRDCNTH ESLLEVCDDY NLNENEYFFD RHPGAFTSIL NFYRTGKLHM MEEMCALSFG
121 QELDYWGIDE IYLESCCQAR YHQKKEQMNE ELRREAETMR EREGEEFDNT CCPDKRKKLW
181 DLLEKPNSSV AAKILAIVSI LFIVLSTIAL SLNTLPELQE TDEFGQLNDN RQLAHVEAVC
241 IAWFTMEYLL RFLSSPNKWK FFKGPLNVID LLAILPYYVT IFLTESNKSV LQFQNVRRVV
301 QIFRIMRILR ILKLARHSTG LQSLGFTLRR SYNELGLLIL FLAMGIMIFS SLVFFAEKDE
361 DATKFTSIPA SFWWATITMT TVGYGDIYPK TLLGKIVGGL CCIAGVLVIA LPIPIIVNNF
421 SEFYKEQKRQ EKAIKRREAL ERAKRNGSIV SMNLKDAFAR SMELIDVAVE KAGESANTKD
481 SADDNHLSPS RWKWARKALS ETSSNKSFEN KYQEVSQKDS HEQLNNTSSS SPQHLSAQKL
541 EMLYNEITKT QPHSHPNPDC QEKPERPSAY EEEIEMEEVV CPQEQLAVAQ TEVIVDMKST
601 SSIDSFTSCA TDFTETERSP LPPPSASHLQ MKFPTDLPGT EEHQRARGPP FLTLSREKGP
661 AARDGTLEYA PVDITVNLDA SGSQCGLHSP LQSDNATDSP KSSLKGSNPL KSRSLKVNFK
721 ENRGSAPQTP PSTARPLPVT TADFSLTTPQ HISTILLEET PSQGDRPLLG TEVSAPCQGP
781 SKGLSPRFPK QKLFPFSSRE RRSFTEIDTG DDEDFLELPG AREEKQVDSS PNCFADKPSD
841 GRDPLREEGS VGSSSPQDTG HNCRQDIYHA VSEVKKDSSQ EGCKMENHLF APEIHSNPGD
901 TGYCPTRETS MLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 4.2 nTPM
Expression across tissuesHPA
Tissue
- retina: 4.2 nTPM
- spleen: 2.2 nTPM
- cerebral cortex: 2 nTPM
- pituitary gland: 1 nTPM
- hippocampal formation: 0.8 nTPM
- thymus: 0.8 nTPM
Single-cell type
- cone photoreceptor cells: 5,059 nCPM
- corticotrophs: 1,311 nCPM
- neuroendocrine cells: 864 nCPM
- pituitary stem cells: 793 nCPM
- gonadotrophs: 593 nCPM
- pancreatic islet cells: 560 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 13 nTPM
- cerebral cortex: 13 nTPM
- midbrain: 12 nTPM
- basal ganglia: 12 nTPM
- thalamus: 9.7 nTPM
- medulla oblongata: 9.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNB2.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 115 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- KCNB2-related disorder
- neurodevelopmental syndrome with epilepsy and autism
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.25
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- potassium ion transmembrane transport
- potassium ion transport
- protein homooligomerization
- protein localization to plasma membrane
- regulation of smooth muscle contraction
Molecular functions
- delayed rectifier potassium channel activity
- potassium channel regulator activity
- protein heterodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Potassium channel tetramerisation-type BTB domain
- Potassium channel, voltage dependent, Kv
- Potassium channel, voltage dependent, Kv2
- Ion transport domain
- SKP1/BTB/POZ domain superfamily
- Voltage-dependent channel domain superfamily
- Voltage-gated potassium channel
- Ion transport protein
- BTB/POZ domain
- Kv2 voltage-gated K+ channel
- Potassium channel, voltage dependent, Kv2.2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNB2 as an antibody target. Whether an autoantibody or antibody against KCNB2 could matter depends on whether native KCNB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNB2 is annotated at the cell surface, where native KCNB2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...